Q9H3M7 (TXNIP_HUMAN) Homo sapiens (Human)
Thioredoxin-interacting protein UniProtKBInterProSTRINGInteractive Modelling
Available Structures
11 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| The structure of the TRX and TXNIP complex |
Heteromer P10599; | |||||
| Assess | ||||||
| The structure of the TRX and TXNIP complex |
Heteromer P10599; | |||||
| Assess | ||||||
| Crystal Structure of tandem WW domains of ITCH in complex with TXNIP peptide |
Heteromer Q96J02; | 72×UNX; | ||||
| Assess | ||||||
| Crystal Structure of WW4 domain of ITCH in complex with TXNIP peptide |
Heteromer Q96J02; | 17×UNX; | ||||
| Assess | ||||||
| Crystal structure of PTPN11 tandem SH2 domains in complex with a TXNIP peptide |
Heteromer Q06124; | 7×UNX; | ||||
| Assess | ||||||
| Crystal Structure of ITCH WW3 domain in complex with TXNIP peptide |
Heteromer Q96J02; | 26×UNX; | ||||
| Assess | ||||||
| Crystal Structure of WW3 domain of ITCH in complex with TXNIP peptide |
Heteromer Q96J02; | |||||
| Assess | ||||||
| Crystal Structure of the VAV2 SH2 domain in complex with TXNIP phosphorylated peptide |
Heteromer P52735; | 4×UNX; | ||||
| Assess | ||||||
| Crystal structure of the N-terminal domain of TXNIP | monomer | 1×GOL; | ||||
| Assess | ||||||
| N-terminal domain of VDUP-1 | monomer | |||||
| Assess | ||||||
| N-terminal domain of VDUP-1 | monomer | 1×CA; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4ll1.1.A | monomer | 0.82 | 98.73 | |||
| Assess | ||||||
| 7usy.1.G | monomer | 0.56 | 19.77 | |||
| Assess | ||||||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 4ll1.1.C | monomer | 0.57 | 98.25 | ||
| Assess | ||||||